COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 348: Articles 3471-3480  | Next

Bivalent mRNA vaccine effectiveness against COVID-19 infections, hospitalisations and deaths in Portugal: a cohort study based on electronic health records, September 2022 to May 2023
Machado, A., Kislaya, I., Soares, P., Magalhaes, S., Rodrigues, A. P., Franco, R., Leite, P. P., Dias, C. M., Nunes, B.
10.1101/2023.09.05.23295025 — Posted: 2023-09-05
Individual and spatial determinants of mortality during the Covid-19 pandemic: The case of Belgium in 2020
Bourguignon, M., Bertrand, A., Damiens, J., Doignon, Y., Eggerickx, T., Plavsic, A., Sanderson, J.-P.
10.1101/2023.09.04.23295014 — Posted: 2023-09-05
Differentiation of COVID-19 from other emergency infectious disease presentations using whole blood transcriptomics then rapid qPCR: a case-control and observational cohort study
Li, H. K., Jackson, H. R., Miglietta, L., Habgood-Coote, D., Mills, E., Mehta, R., Hamady, A., Haber, A., Amran, M., Hammond, R., Arancon, D., Cooke, G. S., Noursadeghi, M., Openshaw, P. J., Rodriguez Manzano, J., Kaforou, M., Sriskandan, S.
10.1101/2023.09.03.23294989 — Posted: 2023-09-05
Emerging Links Between COVID-19 and Cardiovascular & Cerebrovascular Thromboembolic Events: A Systematic Review
Agarwal, A., Panjiyar, B. K., Patel, D. M., Ghotra, M., Husain, M. G. N., Upadhyay, R. B.
10.1101/2023.09.05.23295067 — Posted: 2023-09-05
Psychotherapies and Psychological Support for Individuals Facing Psychological Distress during the COVID-19 Pandemic: A Scoping Review
Yagihashi, M., Sakuma, A., Murakami, M.
10.1101/2023.09.04.23295013 — Posted: 2023-09-05
Correlation of myeloid-derived suppressor cell expansion with upregulated transposable elements in severe COVID-19 unveiled in single-cell RNA sequencing reanalysis
Farahmandnejad, M., Mosadeghi, P., Dorvash, M., Sakhteman, A., Faridi, P., Negahdaripour, M.
10.1101/2023.09.04.556192 — Posted: 2023-09-05
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86
Lasrado, N., Collier, A.-r., Hachmann, N., Miller, J., Rowe, M., Schonberg, E., Rodrigues, S., LaPiana, A., Patio, R., Anand, T., Fisher, J., Mazurek, C., Guan, R., Wagh, K., Theiler, J., Korber, B., Barouch, D. H.
10.1101/2023.09.04.556272 — Posted: 2023-09-05
Deep unsupervised learning methods for the identification and characterization of TCR specificity to Sars-Cov-2
Miraoui, Y. N.
10.1101/2023.09.05.556326 — Posted: 2023-09-05
COVID-19 vaccines and autoimmune disorders: A scoping review protocol
Chaufan, C., Manwell, L., Heredia, C., McDonald, J.
10.1101/2023.09.03.23295001 — Posted: 2023-09-04
Neutralization of SARS-CoV-2 EG.5/EG.5.1 by sera from ZF2001 RBD-dimer and its next-generation vaccines
An, Y., Zhou, X., Tao, L., Xie, H., Yang, C., Li, D., Wang, R., Hu, H., Liu, K., Dai, L., Xu, K., Gao, G. F.
10.1101/2023.09.02.556038 — Posted: 2023-09-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).